SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (10165)6/28/1998 10:49:00 AM
From: jack w garnes jr.  Respond to of 23519
 
AT,
Thanks for the hype <g> JG



To: AlienTech who wrote (10165)6/28/1998 11:17:00 AM
From: blankmind  Read Replies (2) | Respond to of 23519
 
- Coming from BigScane means a lot.

- BigScane's most recent prediction that came true was that "fda approval would come next week" and it did.

- BigScane also said that Vivus was having packaging labels made up for the Russian, Canadian, and I think Chinese markets.

- Bottom line: when BigScane speaks, we had better listen. Because he knows what he's talking about.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News